Human galectin-3 canonical carbohydrate-site binding: molecular mechanisms & dependencies

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

Human evidence only

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

Tested pectic preparations were weak or inactive canonical-site inhibitors; reported pectic IC50 values, where measurable, exceeded 10 mg/mL.
Modified citrus pectin, product-specific → Human galectin-3 canonical carbohydrate-site binding source_derived_draftungraded
Experimental context and source evidence
evidence_span
{"source_cache": "artifacts/pectin-research/27129206.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b9faed8d7344a109bfebf8e340281cc15375deb88a653cd129967a7084e9eb12", "start_char": 0, "end_char": 1776, "text_sha256": "b9faed8d7344a109bfebf8e340281cc15375deb88a653cd129967a7084e9eb12"}
experimental_model
Fluorescence-anisotropy competition and cell assays
exposure
Panel of bioactive pectins including modified products; synthetic pectic fragments
limitations
Preparation- and assay-specific. This challenges a general canonical-site blockade explanation; it does not disprove all physical interactions or every proposed noncanonical mechanism.
nutrient_topic
Pectin research collection; topical membership is not evidence of a direct dietary effect. · Pectin, structurally heterogeneous plant polysaccharides
organism
Recombinant galectins and cultured cells
plain_language
Attaching to a protein does not necessarily block its usual sugar-binding function.
primary_references
[pectin-p27129206] Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans. (2016). https://pubmed.ncbi.nlm.nih.gov/27129206/ DOI: 10.1074/jbc.m116.721464
tissue_or_cell_type
Canonical carbohydrate-binding site
Pectin: metabolism, signaling and nutrient connections (2026-09-17) · lines 464–475
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Fluorescence-anisotropy competition and cell assays · source_derived_draft · unverified_draft
### pectin-gal3-inhibition-limited Tested pectic preparations were weak or inactive canonical-site inhibitors; reported pectic IC50 values, where measurable, exceeded 10 mg/mL. Condition category: normal nutrient_topic: Pectin research collection; topical membership is not evidence of a direct dietary effect. plain_language: Attaching to a protein does not necessarily block its usual sugar-binding function. organism: Recombinant galectins and cultured cells tissue_or_cell_type: Canonical carbohydrate-binding site experimental_model: Fluorescence-anisotropy competition and cell assays limitations: Preparation- and assay-specific. This challenges a general canonical-site blockade explanation; it does not disprove all physical interactions or every proposed noncanonical mechanism. exposure: Panel of bioactive pectins including modified products; synthetic pectic fragments evidence_span: {"source_cache": "artifacts/pectin-research/27129206.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b9faed8d7344a109bfebf8e340281cc15375deb88a653cd129967a7084e9eb12", "start_char": 0, "end_char": 1776, "text_sha256": "b9faed8d7344a109bfebf8e340281cc15375deb88a653cd129967a7084e9eb12"} [pectin-p27129206] Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans. (2016). https://pubmed.ncbi.nlm.nih.gov/27129206/ DOI: 10.1074/jbc.m116.721464
Complete structured claim and evidence
Synthetic fragments representing the common pectic galactan configuration did not inhibit the tested galectins in this competition assay.
Pectic galactan side chains → Human galectin-3 canonical carbohydrate-site binding source_derived_draftungraded
Experimental context and source evidence
evidence_span
{"source_cache": "artifacts/pectin-research/27129206.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b9faed8d7344a109bfebf8e340281cc15375deb88a653cd129967a7084e9eb12", "start_char": 0, "end_char": 1776, "text_sha256": "b9faed8d7344a109bfebf8e340281cc15375deb88a653cd129967a7084e9eb12"}
experimental_model
Fluorescence-anisotropy competition and cell assays
exposure
Panel of bioactive pectins including modified products; synthetic pectic fragments
limitations
Preparation- and assay-specific. This challenges a general canonical-site blockade explanation; it does not disprove all physical interactions or every proposed noncanonical mechanism.
nutrient_topic
Pectin research collection; topical membership is not evidence of a direct dietary effect. · Pectin, structurally heterogeneous plant polysaccharides
organism
Recombinant galectins and cultured cells
plain_language
The expected side-chain motif did not function as a strong blocking agent in this assay.
primary_references
[pectin-p27129206] Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans. (2016). https://pubmed.ncbi.nlm.nih.gov/27129206/ DOI: 10.1074/jbc.m116.721464
tissue_or_cell_type
Canonical carbohydrate-binding site
Pectin: metabolism, signaling and nutrient connections (2026-09-17) · lines 477–488
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Fluorescence-anisotropy competition and cell assays · source_derived_draft · unverified_draft
### pectin-galactan-site-null Synthetic fragments representing the common pectic galactan configuration did not inhibit the tested galectins in this competition assay. Condition category: normal nutrient_topic: Pectin research collection; topical membership is not evidence of a direct dietary effect. plain_language: The expected side-chain motif did not function as a strong blocking agent in this assay. organism: Recombinant galectins and cultured cells tissue_or_cell_type: Canonical carbohydrate-binding site experimental_model: Fluorescence-anisotropy competition and cell assays limitations: Preparation- and assay-specific. This challenges a general canonical-site blockade explanation; it does not disprove all physical interactions or every proposed noncanonical mechanism. exposure: Panel of bioactive pectins including modified products; synthetic pectic fragments evidence_span: {"source_cache": "artifacts/pectin-research/27129206.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "b9faed8d7344a109bfebf8e340281cc15375deb88a653cd129967a7084e9eb12", "start_char": 0, "end_char": 1776, "text_sha256": "b9faed8d7344a109bfebf8e340281cc15375deb88a653cd129967a7084e9eb12"} [pectin-p27129206] Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans. (2016). https://pubmed.ncbi.nlm.nih.gov/27129206/ DOI: 10.1074/jbc.m116.721464
Complete structured claim and evidence

The events it takes part in

A mechanism often involves more than two components. These are the full events, with every participant and its role.

Situations it appears in

Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

Open hypotheses

Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.

This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

Human galectin-3 canonical carbohydrate-site binding